| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| FON_NAZ - Bandi Altre Fondazioni |
All-optical fingerprinting of metastatic potential (5° anno)
|
|
Ongoing | 2023 |
| INTLI - Finanziamenti internazionali |
Ampakine-mediated modulation of neuronal activity for the treatment of Rett syndrome: proposal for a preclinical study
|
|
Ongoing | 2021 |
| DECC - Bando Dipartimenti di Eccellenza |
Assegnazione Dipartimenti di Eccellenza 2023-2027 - Dipartimento di BIOTECNOLOGIE MEDICHE E MEDICINA TRASLAZIONALE
|
|
Ongoing | 2023 |
| PRIN2020 - PRIN bando 2020 |
Breast implants safety: is our knowledge enough?
|
|
Ongoing | 2022 |
| INTLI - Finanziamenti internazionali |
Deciphering the principles of cell decision-making in multicellular system. The Least microEnvironmental Unertainty Pinciples (LEUP)
|
|
Ongoing | 2020 |
| MIS - Bandi Ministero Salute |
Enhancement of the current hematopoietic stem cell-based gene therapy to broaden its accessibility to symptomatic patients affected by Metachromatic Leukodystrophy
|
|
Ongoing | 2021 |
| FON_NAZ - Bandi Altre Fondazioni |
Evidence-based approach to treat hyperexcitability in Rett syndrome though splicing modulation
|
|
Ongoing | 2021 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Fluoxetine reveres cognitive defects in a mouse model of AT: a preclinical study to elucidate the precise mechanism of action
|
|
Ongoing | 2022 |
| FON_NAZ - Bandi Altre Fondazioni |
Functional study on a new pharmacological approach in the Rett Syndrome
|
|
Ongoing | 2023 |
| INTLI - Finanziamenti internazionali |
GM1-oligosaccharide as a new drug candidate for Rett syndrome
|
|
Ongoing | 2021 |
